Molecular Partners Ag (MOLN) Net Cash Flow (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Net Cash Flow for 7 consecutive years, with -$19.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 182.12% year-over-year to -$19.0 million in Q2 2026; TTM through Jun 2026 was -$17.8 million, a 186.37% decrease from a year earlier, with the FY2025 full-year figure at $24.3 million, up 593.72% from the prior year.
• Net Cash Flow was -$19.0 million for Q2 2026 at Molecular Partners Ag, down from -$23577.3 in the prior quarter.
• Over five years, Net Cash Flow peaked at $76.4 million in Q4 2025 and troughed at -$75.1 million in Q3 2025.
• A 5-year average of -$9715.2 and a median of -$11638.6 in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow sank 12108.51% in 2023 and surged 6414.49% in 2025, its largest moves.
• Over 5 years, Net Cash Flow stood at $17.8 million in 2022, then jumped by 79.37% to $31.9 million in 2023, then soared by 52.09% to $48.6 million in 2024, then surged by 57.24% to $76.4 million in 2025, then slumped by 124.93% to -$19.0 million in 2026.
• The last three Net Cash Flow figures came in at -$19.0 million (Q2 2026), -$23577.3 (Q1 2026), and $76.4 million (Q4 2025), per Business Quant data.